# Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)

> **NCT00518570** · NA · COMPLETED · sponsor: **Berkshire Health Systems** · enrollment: 7 (actual)

## Conditions studied

- Premenstrual Dysphoric Disorder

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00518570
- **Lead sponsor:** Berkshire Health Systems
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2007-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518570, "Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00518570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*